Atossa Therapeutics Strengthens Clinical Leadership Team with the Addition of Two Experienced Biopharma Executives

Previously, Dr. Theall held senior roles at Pfizer Inc., where she contributed to the clinical development of IBRANCE® (palbociclib), including the PALOMA trials that supported both accelerated and full approvals. She began her career in academic medicine, serving in leadership roles at Tufts Medical Center and as a clinical investigator across more than 40 oncology studies. Atossa Therapeutics Strengthens Clinical Leadership Team with the Addition of Two Experienced Biopharma Executives Accessibility State ...